Amy Goodman
@DemocracyNow·3.2M subscribers·19.4K videos
What Went Wrong with AstraZeneca's Vaccine Trial? CEO Only Shares Details with Investors
Posted
September 11, 2020
Views
21,591
Likes
517
Comments
122
Engagement
September 11, 2020
21,591
517
122
2.96%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
7:09Now PlayingAs the world races to find a COVID-19 vaccine, one of the most promising vaccine trials has hit a major roadblock. AstraZeneca paused its Phase 3 COVID-19 vaccine trial after a woman in the trial developed severe neurological symptoms consistent with transverse myelitis, or inflammation of the spinal cord. Details were only revealed during a CEO call with investors, and "everyone was left to guess what went wrong," writes Ed Silverman, senior writer at the health news site STAT, which broke the story. Silverman says the halting of the U.K. trial raises several issues, including whether pharmaceutical companies are being pushed to move faster than is safe. "Is the FDA being pushed to authorize or approve a vaccine faster than it should?"
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 89AM ET
Please consider supporting independent media by making a donation to Democracy Now! today
FOLLOW DEMOCRACY NOW! ONLINE:
Daily Email Digest
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
